In Vitro Fertilisation is a form of assisted reproduction in which eggs are collected from the ovaries and fertilised with sperm outside the body under laboratory conditions, after which resulting embryos may be transferred to the uterus or cryopreserved for future use. The phrase "in vitro" literally means "in glass", reflecting the historical use of laboratory vessels for biological experiments.
In Vitro Fertilisation separates several stages of reproduction that normally occur within the reproductive tract: egg maturation is stimulated and monitored, eggs are retrieved, fertilisation occurs in the laboratory, embryos develop under controlled conditions and an embryo can subsequently be placed into the uterus. The technique can bypass blocked or damaged fallopian tubes and can assist in situations involving severe sperm-factor infertility, ovulatory disorders, unexplained infertility and other reproductive conditions. It is also used with donor gametes and previously frozen reproductive material. The treatment does not guarantee pregnancy because fertilisation, embryo development, implantation and pregnancy progression remain biologically selective processes.
A typical In Vitro Fertilisation cycle involves controlled ovarian stimulation so that multiple follicles develop rather than relying on the single dominant follicle of an unmedicated menstrual cycle. Ultrasound and hormone measurements are used to monitor response and minimise excessive stimulation. Once appropriate follicular development is achieved, medication induces final egg maturation and egg retrieval is scheduled. Retrieval is usually performed using a needle guided by transvaginal ultrasound, with sedation or anaesthesia according to clinical circumstances.
Sperm are collected around the time of retrieval or obtained from cryopreserved material or through specialist retrieval procedures when necessary. Eggs and sperm are then brought together in the laboratory, either through conventional insemination or through intracytoplasmic sperm injection when there is a suitable indication. Fertilised eggs develop into embryos under controlled laboratory conditions. Embryologists assess development using established morphological and increasingly time-lapse-based approaches, although appearance alone cannot perfectly predict implantation or genetic competence.
Fertilisation is a critical stage in In Vitro Fertilisation because not every retrieved egg is mature and not every mature egg fertilises. Conventional insemination allows sperm to interact with the egg under laboratory conditions, while intracytoplasmic sperm injection involves injecting a selected sperm directly into an egg. Intracytoplasmic sperm injection is especially useful when sperm concentration, movement or prior fertilisation performance creates a significant barrier, although it is not automatically necessary for every In Vitro Fertilisation cycle.
After fertilisation, embryos undergo early cell divisions. Many embryos naturally stop developing because of chromosomal or cellular abnormalities, so the number of embryos available for transfer can be substantially smaller than the number of eggs initially retrieved. Embryos may reach a stage called the blastocyst stage several days after fertilisation, at which point suitable embryos can be selected for transfer or freezing. Embryo development in the laboratory therefore provides a form of biological selection but cannot guarantee which embryo will implant or produce a healthy birth.
Embryo transfer is the stage at which an embryo is placed into the uterus using a thin catheter passed through the cervix. Transfer can occur during the same treatment cycle or during a later frozen-embryo cycle. Frozen transfer allows the uterus to be prepared separately from ovarian stimulation and provides flexibility when fresh transfer is not advisable or when embryos have been cryopreserved for future use.
Vitrification has substantially improved survival of many embryos during freezing and thawing by rapidly reducing the formation of damaging ice crystals. Current practice often favours transfer of a single embryo when clinically appropriate because transferring multiple embryos increases the probability of twins or higher-order pregnancies, which carry greater obstetric and neonatal risks. After transfer, implantation may occur several days later, followed by development of a pregnancy. A positive pregnancy test indicates biochemical evidence of pregnancy but does not itself guarantee ongoing pregnancy or live birth, so subsequent ultrasound assessment is important.
In Vitro Fertilisation is used for numerous indications. It can bypass damaged or blocked fallopian tubes because fertilisation occurs outside the reproductive tract. It can also assist when sperm have substantial difficulty reaching or fertilising an egg, when ovulation cannot be adequately restored through simpler treatment, or when previous fertility treatments have been unsuccessful.
Some couples with unexplained infertility may undergo In Vitro Fertilisation because it can overcome several possible barriers simultaneously, although the precise mechanism of unexplained infertility may remain unknown. Donor eggs can allow pregnancy when a person's own eggs are unavailable or unlikely to produce suitable embryos, while donor sperm can be used when sperm production is absent or severely impaired. Frozen eggs or embryos can be incorporated into treatment following Fertility Preservation. In selected circumstances, preimplantation genetic testing can be used to examine embryos for particular genetic or chromosomal characteristics before transfer, but such testing has defined limitations and cannot guarantee a genetically or medically unaffected child.
Success rates vary substantially according to age, ovarian reserve, sperm characteristics, embryo development, uterine factors, underlying disease and treatment history. A cycle can involve several stages at which numbers decline: not all follicles yield mature eggs, not all mature eggs fertilise, not all fertilised eggs develop into suitable embryos and not every transferred embryo implants. Egg age is particularly important because chromosomal abnormalities in eggs become more frequent with reproductive ageing.
Consequently, a technically successful retrieval or fertilisation rate does not equal a live-birth probability. Clinics may report outcomes using different denominators, including per retrieval, per embryo transfer or cumulative outcomes across multiple transfers from one retrieval. Patients therefore need to understand exactly what a reported percentage represents. Individual prognosis cannot be determined accurately from a population statistic alone, because medical history and biological response vary considerably between patients.
In Vitro Fertilisation involves several potential risks. Ovarian stimulation can produce excessive ovarian response and, in some patients, ovarian hyperstimulation syndrome. Egg retrieval can rarely cause bleeding, infection or injury to adjacent structures. Pregnancy following treatment can involve ectopic pregnancy, miscarriage or complications associated with multiple gestation. The principal preventable risk of multiple pregnancy is reduced through careful embryo-transfer strategies. Emotional stress can arise from repeated treatment cycles, uncertain outcomes and the financial or logistical demands of frequent appointments.
Hormonal medicines can produce temporary symptoms such as abdominal discomfort, headaches, breast tenderness or mood changes. Severe complications are uncommon in appropriately monitored treatment, but risk is influenced by individual health and protocol. Appropriate counselling therefore includes both the potential benefits of bypassing specific reproductive barriers and the limitations and risks inherent in ovarian stimulation, egg retrieval, laboratory procedures and pregnancy.
The history of In Vitro Fertilisation illustrates the transition from experimental reproductive biology to established clinical medicine. Early research demonstrated that mammalian eggs could be fertilised and developed outside the body, eventually leading to successful human treatment. Advances in ovarian stimulation, ultrasound-guided retrieval, embryo culture, cryopreservation and micromanipulation greatly improved clinical possibilities. Modern laboratories carefully control temperature, gas composition, pH, osmolarity and other environmental conditions because embryos are sensitive to changes in their surroundings.
Embryology has also become increasingly quantitative, using detailed observation of cell division and development to support embryo selection. Despite technological advances, the fundamental biological uncertainties of embryo competence and implantation remain. A common misconception is that In Vitro Fertilisation creates a pregnancy entirely in a laboratory; the laboratory controls fertilisation and early embryo development, but implantation and the remainder of pregnancy occur within the uterus. Its significance lies in selectively relocating and controlling particular reproductive steps while leaving many biological processes subject to natural variation.
